Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Barragan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Ebiomedicine|September 28, 2020
Epigenetics modulates the complexity of the response to Immune Checkpoint BlockadeIsabel Barragan
Journal of Genetic Counseling|February 21, 2009
Diversity through the eyes of a minority studentDeborah Isabel Barragan
Trends in Pharmacological Sciences|July 5, 2014
Epigenetic mechanisms of importance for drug treatmentMaxim Ivanov, Isabel Barragan, Magnus Ingelman-Sundberg
Annual Review of Pharmacology and Toxicology|October 15, 2017
Pharmacoepigenetics and Toxicoepigenetics: Novel Mechanistic Insights and Therapeutic OpportunitiesVolker M Lauschke, Isabel Barragan, Magnus Ingelman-Sundberg
Ophthalmic Research|March 5, 2005
Molecular analysis of RIM1 in autosomal recessive Retinitis pigmentosaIsabel Barragan, Irene Marcos, Salud Borrego, et al.
International Journal of Molecular Medicine|November 8, 2005
Mutation screening of three candidate genes, ELOVL5, SMAP1 and GLULD1 in autosomal recessive retinitis pigmentosaIsabel Barragan, Irene Marcos, Salud Borrego, et al.
International Journal of Pharmaceutics|January 21, 2006
Effects of incorporated drugs on degradation of novel 2,2'-bis(2-oxazoline) linked poly(lactic acid) filmsTommy Tarvainen, Minna Malin, Isabel Barragan, et al.
British Journal of Cancer|February 10, 2023
Preclinical models in head and neck squamous cell carcinomaPatricia Chaves, María Garrido, Javier Oliver, et al.
Pharmacogenomics|October 8, 2019
CYP3A5 is unlikely to mediate anticancer drug resistance in hepatocellular carcinomaVolker M Lauschke, Åsa Nordling, Yitian Zhou, et al.
Cancers|July 26, 2020
Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular PredictorsMaría Rosario Chica-Parrado, Ana Godoy-Ortiz, Begoña Jiménez, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Ebiomedicine|September 28, 2020
Epigenetics modulates the complexity of the response to Immune Checkpoint BlockadeIsabel Barragan
Journal of Genetic Counseling|February 21, 2009
Diversity through the eyes of a minority studentDeborah Isabel Barragan
Trends in Pharmacological Sciences|July 5, 2014
Epigenetic mechanisms of importance for drug treatmentMaxim Ivanov, Isabel Barragan, Magnus Ingelman-Sundberg
Annual Review of Pharmacology and Toxicology|October 15, 2017
Pharmacoepigenetics and Toxicoepigenetics: Novel Mechanistic Insights and Therapeutic OpportunitiesVolker M Lauschke, Isabel Barragan, Magnus Ingelman-Sundberg
Ophthalmic Research|March 5, 2005
Molecular analysis of RIM1 in autosomal recessive Retinitis pigmentosaIsabel Barragan, Irene Marcos, Salud Borrego, et al.
International Journal of Molecular Medicine|November 8, 2005
Mutation screening of three candidate genes, ELOVL5, SMAP1 and GLULD1 in autosomal recessive retinitis pigmentosaIsabel Barragan, Irene Marcos, Salud Borrego, et al.
International Journal of Pharmaceutics|January 21, 2006
Effects of incorporated drugs on degradation of novel 2,2'-bis(2-oxazoline) linked poly(lactic acid) filmsTommy Tarvainen, Minna Malin, Isabel Barragan, et al.
British Journal of Cancer|February 10, 2023
Preclinical models in head and neck squamous cell carcinomaPatricia Chaves, María Garrido, Javier Oliver, et al.
Pharmacogenomics|October 8, 2019
CYP3A5 is unlikely to mediate anticancer drug resistance in hepatocellular carcinomaVolker M Lauschke, Åsa Nordling, Yitian Zhou, et al.
Cancers|July 26, 2020
Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular PredictorsMaría Rosario Chica-Parrado, Ana Godoy-Ortiz, Begoña Jiménez, et al.
Pageof 3